|
Anshan Hifichem Co., Ltd. (300758.SZ) DCF Valuation
CN | Basic Materials | Chemicals - Specialty | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Anshan Hifichem Co., Ltd. (300758.SZ) Bundle
Discover the true value of Anshan Hifichem Co., Ltd. (300758SZ) with our advanced DCF Calculator! Adjust critical assumptions, explore various scenarios, and evaluate the effects of changes on Anshan Hifichem Co., Ltd. (300758SZ) valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 694.6 | 1,008.3 | 1,346.9 | 1,208.6 | 1,217.8 | 1,428.6 | 1,675.9 | 1,966.1 | 2,306.4 | 2,705.6 |
| Revenue Growth, % | 0 | 45.17 | 33.58 | -10.27 | 0.76701 | 17.31 | 17.31 | 17.31 | 17.31 | 17.31 |
| EBITDA | 161.0 | 279.0 | 328.3 | 150.9 | 185.0 | 294.0 | 344.9 | 404.6 | 474.7 | 556.8 |
| EBITDA, % | 23.18 | 27.67 | 24.37 | 12.49 | 15.19 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 |
| Depreciation | 35.8 | 59.5 | 92.8 | 135.5 | 141.0 | 116.4 | 136.5 | 160.1 | 187.9 | 220.4 |
| Depreciation, % | 5.15 | 5.9 | 6.89 | 11.21 | 11.58 | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 |
| EBIT | 125.2 | 219.5 | 235.5 | 15.4 | 44.0 | 177.7 | 208.4 | 244.5 | 286.8 | 336.5 |
| EBIT, % | 18.03 | 21.77 | 17.49 | 1.27 | 3.62 | 12.44 | 12.44 | 12.44 | 12.44 | 12.44 |
| Total Cash | 401.0 | 246.8 | 313.3 | 541.2 | 259.2 | 490.1 | 575.0 | 674.5 | 791.3 | 928.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 258.7 | 396.4 | 437.1 | 343.9 | 409.1 | 488.7 | 573.3 | 672.6 | 789.0 | 925.6 |
| Account Receivables, % | 37.25 | 39.31 | 32.45 | 28.45 | 33.59 | 34.21 | 34.21 | 34.21 | 34.21 | 34.21 |
| Inventories | 154.5 | 227.8 | 333.2 | 379.8 | 337.5 | 367.8 | 431.4 | 506.1 | 593.7 | 696.5 |
| Inventories, % | 22.25 | 22.59 | 24.74 | 31.42 | 27.71 | 25.74 | 25.74 | 25.74 | 25.74 | 25.74 |
| Accounts Payable | 57.3 | 123.5 | 36.1 | 85.5 | 151.1 | 121.9 | 143.0 | 167.7 | 196.8 | 230.9 |
| Accounts Payable, % | 8.25 | 12.24 | 2.68 | 7.08 | 12.41 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
| Capital Expenditure | -147.3 | -234.1 | -161.7 | -191.6 | -165.3 | -245.3 | -287.8 | -337.6 | -396.1 | -464.7 |
| Capital Expenditure, % | -21.21 | -23.22 | -12.01 | -15.86 | -13.58 | -17.17 | -17.17 | -17.17 | -17.17 | -17.17 |
| Tax Rate, % | -35.38 | -35.38 | -35.38 | -35.38 | -35.38 | -35.38 | -35.38 | -35.38 | -35.38 | -35.38 |
| EBITAT | 110.6 | 182.4 | 191.9 | 12.1 | 59.6 | 153.2 | 179.8 | 210.9 | 247.4 | 290.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -356.8 | -137.1 | -110.6 | 52.0 | 77.9 | -114.9 | -98.7 | -115.8 | -135.9 | -159.4 |
| WACC, % | 10.63 | 10.6 | 10.59 | 10.57 | 10.71 | 10.62 | 10.62 | 10.62 | 10.62 | 10.62 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -457.1 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -166 | |||||||||
| Terminal Value | -2,503 | |||||||||
| Present Terminal Value | -1,511 | |||||||||
| Enterprise Value | -1,968 | |||||||||
| Net Debt | 94 | |||||||||
| Equity Value | -2,063 | |||||||||
| Diluted Shares Outstanding, MM | 367 | |||||||||
| Equity Value Per Share | -5.62 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled real Anshan Hifichem Co., Ltd. (300758SZ) financial data.
- Authentic Data: Historical financial figures and forward-looking projections (highlighted in the yellow cells).
- Adaptive Forecasting: Modify key forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Anshan Hifichem Co., Ltd. (300758SZ).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Interface: Organized for clarity and straightforward navigation, complete with step-by-step guidance.
Core Features
- Customizable Financial Assumptions: Adjust key inputs such as revenue projections, EBITDA percentages, and capital expenditures for precise analysis.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and various financial metrics without delay.
- High-Precision Accuracy: Incorporates Anshan Hifichem Co., Ltd.'s (300758SZ) actual financial data for credible valuation insights.
- Simplified Scenario Analysis: Effortlessly explore different scenarios and evaluate their results for informed decision-making.
- Efficiency Booster: Reduces the necessity of developing complex valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review the pre-filled data for Anshan Hifichem Co., Ltd. (300758SZ) (historical and projected).
- Step 3: Modify key assumptions (highlighted in yellow) based on your analysis.
- Step 4: Observe automatic updates for Anshan Hifichem Co., Ltd.'s intrinsic value.
- Step 5: Utilize the results for your investment strategies or reporting purposes.
Why Choose Anshan Hifichem Co., Ltd. (300758SZ)?
- User-Friendly Design: Perfectly suited for both novices and seasoned professionals.
- Customizable Inputs: Tailor assumptions easily to suit your analysis needs.
- Real-Time Adjustments: Observe immediate changes in Anshan Hifichem's valuation as you modify parameters.
- Pre-Configured Data: Comes with Anshan Hifichem's actual financials, allowing for swift analysis.
- Relied Upon by Experts: Frequently utilized by investors and analysts for informed decision-making.
Who Can Benefit from Our Product?
- Institutional Investors: Develop comprehensive and accurate valuation models for portfolio evaluation.
- Corporate Finance Departments: Assess valuation scenarios to inform strategic decision-making.
- Financial Consultants and Advisors: Deliver precise valuation insights for Anshan Hifichem Co., Ltd. (300758SZ) to clients.
- Students and Instructors: Utilize real-world data to enhance financial modeling practices and education.
- Industry Enthusiasts: Gain insights into how companies like Anshan Hifichem Co., Ltd. (300758SZ) are appraised in the market.
Contents of the Template
- Preloaded Hifichem Data: Historical and forecasted financial information, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: High-quality templates for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted fields for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financial reports for in-depth analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios for performance evaluation.
- Dashboard and Charts: Visual overviews of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.